What Is Ipamorelin? A Complete 2026 Guide to the GH Peptide

Ipamorelin is a synthetic peptide that signals your pituitary gland to release your body's own growth hormone. Researchers call it a selective growth hormone secretagogue because, in studies, it prompts GH release without meaningfully raising cortisol or prolactin. Novo Nordisk first developed it, and it reached phase II trials before being shelved. Today it's studied for recovery, lean mass, and sleep. Its compounding status is under FDA review, so pru's live growth hormone peptide is sermorelin.

What is ipamorelin?

Ipamorelin is a synthetic pentapeptide that tells the pituitary gland to release growth hormone (GH). It belongs to a family called growth hormone secretagogues, which means it prompts your body to make more of its own GH rather than adding GH from outside. Its amino acid sequence is Aib-His-D-2-Nal-D-Phe-Lys-NH2, and it was derived from an earlier peptide called GHRP-1.

Ipamorelin was first developed by Novo Nordisk under the code NNC 26-0161 and described in a 1998 study as "the first selective growth hormone secretagogue." It later reached phase II human trials for postoperative ileus, but development was discontinued. Because of that, ipamorelin is thought of today as a research peptide, and its use in compounding is under active FDA review.

How does ipamorelin work in the body?

Ipamorelin works by binding to the growth hormone secretagogue receptor (GHS-R1a), the same receptor the hunger hormone ghrelin uses. This receptor sits mainly in the anterior pituitary gland. When ipamorelin binds it, the pituitary's somatotroph cells release a pulse of stored growth hormone into the blood.

What makes ipamorelin different from many older GH-releasing peptides is selectivity. In the original 1998 research, ipamorelin raised GH without significantly raising cortisol or ACTH, even at doses more than 200 times higher than the amount needed to release GH. It also did not measurably move prolactin. Ipamorelin also tends to preserve the body's natural pulse-and-recovery rhythm of GH release rather than forcing a constant flood, which keeps normal feedback signals intact.

• Ipamorelin binds the ghrelin (GHS-R1a) receptor in the pituitary.
• It triggers a pulse of your own growth hormone.
• In studies it did this without raising cortisol or prolactin at typical doses.
• Its elimination half-life is roughly 2 hours, so its action is short and pulse-like.

What is ipamorelin studied for?

Ipamorelin is studied for the same areas tied to healthy growth hormone signaling: body composition, recovery, and sleep. Because it acts on the ghrelin receptor to prompt GH release in natural pulses, researchers study it for how those pulses can support the body's own repair and rest cycles.

Because growth hormone plays a role in how the body builds lean tissue, repairs, and rests, GH-releasing peptides like ipamorelin are thought to support those processes. Here's how researchers and clinicians tend to describe the interest in ipamorelin:

• Lean-mass support: GH signaling is tied to how the body maintains muscle, so ipamorelin is studied for lean-mass and body-composition support.
• Recovery and repair: higher GH pulses are thought to support tissue recovery after training or physical stress.
• Sleep quality: GH is released heavily during deep sleep, so ipamorelin is studied for how its GH pulses can support deeper rest.
• Selective action: its clean profile in research, raising GH without moving cortisol or prolactin, is the main reason it drew scientific attention.

If your goal is growth hormone support that you can access through a licensed physician today, the closest live option at pru is sermorelin, a GH-releasing peptide with a longer clinical track record. Paying attention to how your body recovers and rebuilds now is the kind of proactive step that tends to pay off over time.

Ipamorelin vs sermorelin vs CJC-1295: how do they compare?

Ipamorelin, sermorelin, and CJC-1295 are all growth hormone peptides, but they don't work the same way. Ipamorelin and CJC-1295 are often confused because they're studied together, while sermorelin works through a different receptor entirely. The table below is an at-a-glance comparison.

A common research pairing is ipamorelin plus a GHRH analogue like CJC-1295, because the two act on different receptors. You can read more in the CJC-1295 and ipamorelin stack guide and the head-to-head sermorelin vs ipamorelin breakdown.

How is ipamorelin dosed?

Ipamorelin is studied as a small subcutaneous injection, and any real dosing should come from a licensed prescriber, not a forum or a vial label. Because ipamorelin isn't available for legal compounding right now, there's no pharmacy-grade dosing pru can offer for it, and self-dosing grey-market product carries real risk (more on that below).

In general, GH-releasing peptides are studied at microgram-level doses timed around sleep or training, because that's when the body's own GH release is highest. Ipamorelin's short half-life (about 2 hours) is why research protocols often describe more than one dose per day. For a fuller walkthrough of how these peptides are dosed and titrated, see the ipamorelin dosage guide and the sermorelin dosage guide for a peptide you can actually get through pru.

Is ipamorelin safe, and what are the side effects?

In research on ipamorelin and in clinical use of similar GH-releasing peptides, reported side effects have generally been mild. A licensed physician reviews your history before anything is prescribed.

Side effects that have been reported or would be expected with growth hormone peptides include:

• Injection-site reactions like redness, itching, or a small bump
• Headache
• Flushing or a warm feeling shortly after a dose
• Water retention or mild swelling
• Increased appetite, since ipamorelin acts on the ghrelin receptor
• Tiredness or lightheadedness

Growth hormone peptides generally aren't recommended for people who are pregnant or breastfeeding, or for anyone with an active cancer, since GH signaling can affect cell growth. A licensed physician reviews your history to flag concerns like these before anything is prescribed. You can read the fuller sermorelin side effects guide for a closely related peptide.

Is ipamorelin legal, and what's its FDA status in 2026?

Ipamorelin's status is best described as under review. In September 2024 the FDA removed ipamorelin acetate from Category 2 of its interim 503A bulk substances list after the original nomination was withdrawn. At the October 2024 Pharmacy Compounding Advisory Committee (PCAC) meeting, the FDA reviewed ipamorelin and recommended against adding it to the 503A bulks list at that time. The result is that ipamorelin sits in regulatory limbo: not banned outright, but not currently cleared for legal 503A compounding either.

This is part of a much larger 2026 peptide moment. The FDA's PCAC is scheduled to review a slate of peptides at its July 23-24, 2026 meeting, and the whole compounded-peptide landscape is shifting. pru's approach is to follow the PCAC process and offer growth hormone peptides only where a licensed physician can prescribe and an FDA-regulated 503A pharmacy can legally compound them. Today, that means sermorelin, not ipamorelin.

How does pru handle growth hormone peptides like ipamorelin?

pru handles growth hormone peptides the same way it handles everything: a licensed physician prescribes, and an FDA-regulated 503A pharmacy compounds and fills. Because ipamorelin isn't currently available for legal compounding, pru doesn't offer it. Instead, pru's live growth hormone peptide is sermorelin, a GHRH analogue with a longer clinical history and a clear compounding path.

Sermorelin is a good example of how pru's model works. It was once an FDA-approved drug (Geref), and the FDA has confirmed Geref wasn't pulled for safety reasons, which is what lets a 503A pharmacy compound pharmacy-grade sermorelin today. It's not the same product as branded GH, and pru describes what sermorelin is studied for. You browse the growth hormone peptides guide, select what interests you, and a physician confirms fit.

On price, pru charges a flat membership of about $50 a month, billed annually, that funds the platform. The peptide itself is sold separately, at cost: the pharmacy fill, supplies, shipping, consult, and a small platform fee, itemized, with no markup on the medicine. As your dose rises the medicine can cost a little more, but it never carries a member markup.

See pricing for the full breakdown, or explore the live sermorelin product page. Being proactive about how you age and recover is a smart, responsible choice, and pru exists to make that choice the accessible one: licensed physicians, pharmacy-grade medicine, and at-cost pricing. Take the next step when you're ready.

Related reading

• Sermorelin: the complete guide
• Sermorelin vs ipamorelin: how they compare
• Growth hormone peptides guide
• CJC-1295 and ipamorelin stack, explained
• Best peptides for muscle growth
• Shop the sermorelin product page

Common questions